Skip to main content
Full access
Letter to the Editor
Published Online: 1 January 2005

Dr. Lespérance and Colleagues Reply

Publication: American Journal of Psychiatry
To the Editor: The interesting letter from Dr. Lyness et al. informs us of a study they carried out that paralleled our results in finding no association between an inflammatory marker, interleukin-1β, and depression in a group of cardiac patients. However, that study included only 27 subjects, and only four had a current major depression, making the meaning of a lack of relationship between depression and this inflammatory marker unclear. In addition, interleukin-1β is not the same as interleukin-6, which is the cytokine that has been found to predict cardiac events.
We agree with Dr. Lyness et al. that we may not have been able to find an association between interleukin-6 and depression because of the timing of our assessment. We interviewed our subjects approximately 2 months after hospitalization for an acute coronary syndrome. Because the release of interleukin-6 is more dynamic and short term than the release of soluble intercellular adhesion molecule 1 and C-reactive protein, it is conceivable that we missed the peak of the increase in interleukin-6 associated with the acute coronary artery events. Although we could hypothesize that this peak may have been greater among the depressed subjects, by 2 months after the event, it was no longer apparent in our study.
Dr. Lyness et al. are also correct in suggesting that inflammatory markers are likely to correlate with other measures of the severity of cardiac disease that reflect atherosclerotic processes. For example, in our study, interleukin-6 was significantly correlated (all p<0.05) with age; previous myocardial infarction, bypass surgery, or angioplasty; coronary bypass surgery at index; abdominal obesity; high body mass index; low high-density lipoprotein; high blood pressure; high fasting glucose level; high fasting insulin level; and the presence of metabolic syndrome. However, even after statistical control for these potential confounders, there was still no association between depression and interleukin-6 levels in our group.

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 195-a - 195

History

Published online: 1 January 2005
Published in print: January 2005

Authors

Details

FRANÇOIS LESPÉRANCE, M.D.
NANCY FRASURE-SMITH, Ph.D.
MICHAEL IRWIN, M.D.
Montreal, Quebec, Canada

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share